Experimental drug given to Trump to treat COVID-19 wins FDA clearance
It is the second drug of this type—called a monoclonal antibody—to be cleared for COVID-19. The FDA authorized Eli Lilly and Co.’s drug on Nov. 9.
It is the second drug of this type—called a monoclonal antibody—to be cleared for COVID-19. The FDA authorized Eli Lilly and Co.’s drug on Nov. 9.
The state on Saturday reported 40 new COVID-19 deaths, raising the cumulative total during the pandemic to 4,992.
The pandemic has reshaped the most important shopping season of the year, forcing retailers to rethink inventory, store layouts and when, even how, they offer their deepest discounts.
U.S. Treasury Secretary Steven Mnuchin said a decision to end several emergency loan programs being run by the Federal Reserve was based on the fact that the programs were not being heavily utilized.
COVID-19 patients occupy nearly 42% of Indiana’s intensive care beds. The state said only 21.6% of its ICU beds are unoccupied.
In a separate development, the FDA on Thursday gave emergency authorization to use of another anti-inflammatory drug sold by Eli Lilly, baricitinib, to be used with remdesivir.
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
Without data to paint a picture of academic success or failure, Indianapolis Public Schools will likely delay for a year renewing the contracts of four privately run schools under its supervision.
The CDC issued the recommendations just one week before Thanksgiving, at a time when diagnosed infections, hospitalizations and deaths are skyrocketing across the country.
Tyson Foods suspended top officials at its largest pork plant on Thursday and launched an investigation into allegations that they bet on how many workers would get infected during a widespread coronavirus outbreak.
The central bank said it “would prefer that the full suite of emergency facilities established during the coronavirus pandemic continue to serve their important role as a backstop for our still-strained and vulnerable economy.”
Phase III trials are now accumulating the data needed to report results as a renewed surge of the pandemic hits countries around the world.
The state reported 59 new COVID-19 deaths on Thursday, raising the cumulative total during the pandemic to 4,889. Newly reported deaths have reached or topped 25 in Indiana in 23 of the past 24 days.
Initial jobless claims also ticked up in Indiana. Analysts say the worsening pandemic and the arrival of cold weather could accelerate layoffs in the weeks ahead.
Hospitals and nursing homes are searching high and low for doctors, nurses, therapists and support staff to relieve overworked teams, but it is difficult to find people, as all the health systems are looking at the same time.
The state reported 60 new deaths on Tuesday, raising the cumulative total during the pandemic to 4,830. Newly reported deaths have reached or topped 25 in Indiana in 22 of the past 23 days.
The announcement from Pfizer and its German partner BioNTech comes as the team is preparing within days to formally ask U.S. regulators to allow emergency use of the vaccine.
Legislative leaders also said they hoped to stave off cuts to education in the coming budget—or even try to boost funding. But in the midst of the pandemic, leaders say the budget will hinge on coming revenue forecasts.
The announcement by the Food and Drug Administration represents an important step in U.S. efforts to expand testing options for COVID-19. However, the test will require a prescription, likely limiting its initial use.
Federal Reserve Chair Jerome Powell said the threat also means that Congress and the White House should provide more stimulus spending to support the unemployed, states and cities, and small businesses, and to keep the economy afloat.